Supplemental Material, Figure 1 . Study design and experimental timeline. Bar color denotes dose -green, 0 mg PFOA/kg body weight/day; yellow, 1 mg PFOA/kg body weight/day; red, 5 mg PFOA/kg body weight /day; blue, 5 ppb PFOA in drinking waterand bar thickness denotes timing of treatment -thick bars denote on-going direct treatment, thin bars denote only group identity subsequent to treatment. Supplemental Material, Figure 2 . Average daily PFOA consumption on a weekly-basis. PFOA consumption was calculated based on water consumption over the course of a week. For each week an average daily intake for the animals in a given cage was calculated, which was then averaged for the treatment group. Here, the first week of drinking water exposure was initiated on GD7 for P0 dams. Thus, parturition (PND1) occurred approximately after week number 2, before consumption spiked. Lactation occurred during weeks 3-5 (until PND22), when water intake spiked to support fluid needs for milk production. After week 4, intake fell some as the litters began to slowly wean and involution started, reducing milk production. At the end of week 5, all P0 dams were euthanized, so only immature F1 offspring remained at week 6 and later, which had lower water intake than did the mature P0 dams. After weaning, however, as F1 offspring matured between weeks 6 and 13, intake increased slowly. Error bars represent +/-SE.
Estimates of average daily dose from chronic water exposures (Control + 5 ppb PFOA, 1mg/kg + 5ppb) are calculated based on total weekly water consumption, divided by the number of days per week. Cumulative doses from chronic water exposures are calculated based on average daily doses during the given period, multiplied by the number of days in the period. Note, the P0 dams did not receive PFOA in drinking water until GD 7. Thus, the approximate average daily dose during gestation applies for only 12 days (GD7-18), while the approximate average daily dose during lactation applies for 22 days (PND1-22). Average daily dose from acute exposures (1mg/kg PFOA, 5mg/kg PFOA) are calculated based on daily volume administered, as a function of body weight, over the 17-day dosing period. Cumulative doses from acute exposures are calculated by summing the daily administered doses over the treatment period (GD1-17). Note, for this reason cumulative dose does not increase between 
